Europe Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)

Name: Europe Carbapenem-Based Antibiotics Market
SKU: Pharmaceuticals
Rating: 4.8 (17 reviews)

The Europe carbapenem-based antibiotics market is expected to reach US$ 1,469.86 million by 2028 from US$ 1,128.37 million in 2021; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028.

The market's growth is attributed to factors such as the rising prevalence of bacterial infections and increasing private and public partnerships of leading pharmaceutical players. However, the tedious and expensive process of developing antibiotics is expected to restrain the market's growth during the forecast period.

Antimicrobial resistance (AMR) has become a significant threat worldwide. Due to environmental factors such as exposure to antibiotics and spontaneous mutations, bacteria are becoming highly resistant to many antibiotics. Therefore, various strategies are designed to measure and control the spread of AMR. Several governments and healthcare authorities implement constructive plans to combat such critical situations. In 2017, the government of Germany announced the launch of the Global R&D Collaboration Hub to oppose AMR to focus on bridging gaps in the new developments. In January 2019, the UK government launched its strategy to deal with AMR. The UK's government has a 5-year national action plan to deal with antimicrobial resistance. Also, it has the vision to reduce AMR by 2040. The plan was developed across the governments, including Scotland, Wales, and Northern Ireland, and their agencies and administrations with the support of a range of stakeholders.

In April 2020, Venatorx Pharmaceuticals and the Global Antibiotic Research and Development Partnership (GARDP) announced a collaboration to accelerate the development of, and access to, cefepime-taniborbactam. It is a broad-spectrum beta-lactamase inhibitor that restores the activities of cefepime against carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA). However, it is an investigational combination of the fourth-generation antibiotic cefepime with taniborbactam. Under the collaboration, GARDP and Venatorx look forward to developing cefepime-taniborbactam. The combination is under a phase 3 cUTI trial. Additionally, clinical trials in adults with multidrug-resistant infections and clinical development activities and trials to enable cefepime-taniborbactam for children, including newborns with severe bacterial infections, are being conducted. Such activities by public and private partnerships are projected to offer lucrative opportunities for the growth of the carbapenem-based antibiotics market during the forecast period.

Europe Carbapenem-Based Antibiotics Market Revenue and Forecast to 2028 (US$ million)

Get more information on this report :

EUROPE CARBAPENEM-BASED ANTIBIOTICS MARKET SEGMENTATION

By Type

Meropenem
Imipenem
Doripenem
Tebipenem
Others

By Indication

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Carbapenem-based Antibiotics Market – By Type

1.3.2 Europe Carbapenem-based Antibiotics Market – By Indication

1.3.3 Europe Carbapenem-based Antibiotics Market – By Distribution Channel

1.3.4 Europe Carbapenem-based Antibiotics Market – By Country

2. Carbapenem-based Antibiotics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Carbapenem-based Antibiotics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Expert Opinions

5. Carbapenem-based Antibiotics Market – Key Market Dynamics

5.1 Drivers

5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections

5.1.2 Increasing Production of Generic Drugs

5.2 Market Restraints

5.2.1 Tedious and Expensive Process of Antibiotic Development

5.3 Market Opportunities

5.3.1 Private and Public Partnerships

5.4 Future Trends

5.4.1 Strategic Advancement for New Antibiotic Identification

5.5 Impact Analysis

6. Carbapenem-based Antibiotics Market –Europe Analysis

6.1 Europe Carbapenem-based Antibiotics Market Revenue Forecast and Analysis

7. Carbapenem-based Antibiotics Market Analysis – By Type

7.1 Overview

7.2 Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

7.3 Meropenem

7.3.1 Overview

7.3.2 Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Doripenem

7.4.1 Overview

7.4.2 Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Imipenem

7.5.1 Overview

7.5.2 Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Tebipenem

7.6.1 Overview

7.6.2 Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8. Carbapenem-based Antibiotics Market – By Indication

8.1 Overview

8.2 Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

8.3 Bacterial Meningitis

8.3.1 Overview

8.3.2 Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Acute Pelvic Infections

8.4.1 Overview

8.4.2 Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Respiratory Tract Infections

8.5.1 Overview

8.5.2 Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Intra-abdominal Infections

8.6.1 Overview

8.6.2 Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9. Carbapenem-based Antibiotics Market – By Distribution Channel

9.1 Overview

9.2 Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

9.3 Retail Pharmacies

9.3.1 Overview

9.3.2 Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Online Pharmacies

9.4.1 Overview

9.4.2 Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Hospital Pharmacies

9.5.1 Overview

9.5.2 Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10. Carbapenem-based Antibiotics Market –Country Analysis

10.1 Europe: Carbapenem-based Antibiotics Market

10.1.1 Overview

10.1.2 Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.3 Europe: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.4 Europe: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.1.5 Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.6 Europe: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.1.6.1 UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.1 UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.2 UK: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.1.3 UK: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.1.4 UK: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.2 Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.1 Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.2 Germany: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.2.3 Germany: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.2.4 Germany: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.3 France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.1 France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.2 France: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.3.3 France: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.3.4 France: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.4 Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.4.1 Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.4.2 Italy: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.4.3 Italy: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.4.4 Italy: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.5 Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.5.1 Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.5.2 Spain: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.5.3 Spain: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.5.4 Spain: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.6 Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.6.1 Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.6.2 Rest of Europe: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.6.3 Rest of Europe: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.6.4 Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

11. Impact of COVID-19 Pandemic on Europe Carbapenem-based Antibiotics Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Carbapenem-based Antibiotics Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. COMPANY PROFILES

13.1 ACS Dobfar S.p.A

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Iterum Therapeutics plc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Aurobindo Pharma Ltd

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Gland Pharma Limited

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Merck & Co., Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Sumitomo Dainippon Pharma Co., Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Savior Lifetec

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Pfizer Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Spero Therapeutics

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2. Europe: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3. Europe: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4. UK: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. UK: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. UK: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. Germany: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8. Germany: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9. Germany: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10. France: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11. France: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12. France: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13. Italy: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14. Italy: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 15. Italy: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 16. Spain: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 17. Spain: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 18. Spain: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 19. Rest of Europe: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 20. Rest of Europe: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 21. Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 22. Organic Developments in the Carbapenem-based Antibiotics Market

Table 23. Inorganic Developments in the Carbapenem-based Antibiotics Market

Table 24. Glossary of Terms, Carbapenem-based Antibiotics Market

LIST OF FIGURES

Figure 1. Carbapenem-based Antibiotics Market Segmentation

Figure 2. Carbapenem-based Antibiotics Segmentation, By Country

Figure 3. Europe Carbapenem-based Antibiotics Market Overview

Figure 4. The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market

Figure 5. Germany Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)

Figure 6. Europe PEST Analysis

Figure 7. Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints

Figure 8. Europe Carbapenem-based Antibiotics Market – Revenue Forecast and Analysis – 2021- 2028

Figure 9. Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

Figure 10. Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

Figure 16. Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

Figure 23. Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Europe: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 27. Europe: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)

Figure 28. Europe: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

Figure 29. UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 30. Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 31. France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 32. Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 33. Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 34. Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 35. Impact Of COVID-19 Pandemic in Europe Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe carbapenem-based antibiotics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe carbapenem-based antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000